3 Results for "

MGCD-265

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "MGCD-265" in MCE Product Catalog:

2
2 Cited Publications
Referencia número: HY-19642A
No. CAS: 2319837-80-2
Synonyms: MGCD265 hydrochloride
Target:  

TAM Receptor c-Met/HGFR

Áreas de investigación:  

Cancer

Glesatinib hydrochloride (MGCD265 hydrochloride) is an orally active, potent MET/SMO dual inhibitor. Glesatinib hydrochloride, a tyrosine kinase inhibitor, antagonizes P-glycoprotein (P-gp) mediated multidrug resistance (MDR) in non-small cell lung cancer (NSCLC) .
loading...
    loading...
Referencia número: HY-10991
No. CAS: 875337-44-3
Pureza:  98.49%
Target:  

c-Met/HGFR VEGFR Apoptosis

Áreas de investigación:  

Cancer

MGCD-265 analog is a potent and oral active inhibitor of c-Met and VEGFR2 tyrosine kinases, with IC50s of 29 nM and 10 nM, respectively. MGCD-265 analog has significant antitumor activity .
loading...
    loading...
Referencia número: HY-19642
No. CAS: 936694-12-1
Synonyms: MGCD265
Target:  

TAM Receptor c-Met/HGFR

Áreas de investigación:  

Cancer

Glesatinib (MGCD265) is an orally active, potent MET/SMO dual inhibitor. Glesatinib, a tyrosine kinase inhibitor, antagonizes P-glycoprotein (P-gp) mediated multidrug resistance (MDR) in non-small cell lung cancer (NSCLC) .
loading...
    loading...